Prognostic significance of the rho GTPase RHOV and its role in tumor immune cell infiltration: a comprehensive pan‐cancer analysis
FEBS Open Bio · 2023
DOI: 10.1002/2211-5463.13698 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEBS Open Bio, 2023. Verfasst von Qin Qin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Jingzhou Hospital Affiliated to Yangtze University, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Melanoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ras homolog gene family member V (RHOV) is an atypical Rho GTPase that participates in various important cellular processes. Although RHOV has been identified to play an oncogenic role in lung cancer and triple‐negative breast cancer, its role in other types of tumors remains unknown. In this study, we investigated the expression of RHOV in pan‐cancer analysis using The Cancer Genome Atlas (TCGA) and Gene‐Tissue Expression datasets. RHOV mRNA levels were dysregulated in several types of tumors. RHOV expression was identified as an independent prognostic factor in 7 of 33 types of tumors; however, the relationship varied according to tumor type. Higher RHOV expression was associated with a favorable prognosis in kidney renal cell carcinoma and prostate adenocarcinoma, for which RHOV expression was downregulated, whereas RHOV expression was associated with a poor prognosis for patients with adenoid cystic carcinoma, lung adenocarcinoma, pancreatic ductal adenocarcinoma, skin cutaneous melanoma, and uveal melanoma with upregulated RHOV expression. Furthermore, RHOV expression was associated with various clinicopathological parameters in these tumors. RHOV expression showed varied associations with different types of tumor‐infiltrating immune cells and demonstrated a potential impact on the response to immunotherapy depending on the cancer type. Additionally, functional enrichment analysis of RHOV ‐related genes demonstrated a role in a wide range of developmental and immune‐related processes. This study provides valuable insights into the role of RHOV in pan‐cancer development, indicating its role as a tumor suppressor or oncogene according to the cancer type and tumor microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Jingzhou Hospital Affiliated to Yangtze University, China.
- Department of Oncology, The Second People's Hospital of Jingmen, China.
ORCID-Profile: Qin Qin
Zitieren
APA
Qin, Q., & Peng, B. (2023). Prognostic significance of the rho GTPase RHOV and its role in tumor immune cell infiltration: a comprehensive pan‐cancer analysis. FEBS Open Bio. https://doi.org/10.1002/2211-5463.13698
Vancouver
Qin Q, Peng B. Prognostic significance of the rho GTPase RHOV and its role in tumor immune cell infiltration: a comprehensive pan‐cancer analysis. FEBS Open Bio. 2023. doi:10.1002/2211-5463.13698
BibTeX
@article{Qin2023,
author = {Qin, Qin and Peng, Bing},
title = {Prognostic significance of the rho GTPase RHOV and its role in tumor immune cell infiltration: a comprehensive pan‐cancer analysis},
journal = {FEBS Open Bio},
year = {2023},
doi = {10.1002/2211-5463.13698}
}
EUVIMED